Hanne Sand Hansen

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial

Jens Overgaard, Hanne Sand Hansen, Lena Specht et al. · The Lancet · 2003 · 670 citations

Squamous-cell Carcinoma, Radiation Medicine, Radiation Therapy +11

Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer

K. Nygaard, Steinar Hagen, Hanne Sand Hansen et al. · World Journal of Surgery · 1992 · 615 citations

Osteoradionecrosis of the jaws: Clinical characteristics and relation to the field of irradiation

Jens Jørgen Thorn, Hanne Sand Hansen, Lena Specht et al. · Journal of Oral and Maxillofacial Surgery · 2000 · 292 citations

Bone Disease, Osteopathy, Medicine +6

Primary radiotherapy of larynx and pharynx carcinoma—An analysis of some factors influencing local control and survival

Jens Overgaard, Hanne Sand Hansen, Karsten Jøsrgensen et al. · International Journal of Radiation Oncology*Biology*Physics · 1986 · 239 citations

Local Control, Radiation Medicine, Health Sciences +9

Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: Report from the DAHANCA 2 study

Jens Overgaard, Hanne Sand Hansen, A. P. Andersen et al. · International Journal of Radiation Oncology*Biology*Physics · 1989 · 214 citations

Neuro-oncology, Invasive Carcinoma, Medicine +9